A role for Pak protein kinases in Schwann cell transformation

被引:75
作者
Tang, Y
Marwaha, S
Rutkowski, JL
Tennekoon, GI
Phillips, PC
Field, J [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Dept Oncol, Philadelphia, PA 19104 USA
关键词
neurofibrosarcoma; neurofibromatosis; Ras; Rac;
D O I
10.1073/pnas.95.9.5139
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder caused by loss of the NF1 gene, is characterized clinically by neurofibromas and more rarely by neurofibrosarcomas. Neurofibromin, the protein encoded by NF1, possesses an intrinsic GTPase accelerating activity for the Ras proto-oncogene. Through this activity, it is a negative regulator of Ras, The Pak protein kinase is a candidate for a downstream signaling protein that mag mediate Ras signals because it is activated by Rac and Cdc42, two small G proteins required for Ras signaling. Here, we use Pak mutants to explore the role of Pak in Ras signaling in Schwann cells, the cells affected in NF1, Whereas an activated Pak mutant does not transform cells, dominant negative Pak mutants are potent inhibitors of Ras transformation of rat Schwann cells and of a neurofibrosarcoma cell line from an NF1 patient. Although activated Pak stimulated jun-N-terminal kinase, inhibition of Ras transformation by dominant negative Pak did not require inhibition of jun-N-terminal kinase, Instead, the Pak mutants appeared to inhibit transformation by preventing Ras activation of the ERK/mitogen-activated protein kinase cascade. These results have implications for our understanding of NF1 because a neurofibrosarcoma cell line derived from a patient with NF1 was reverted by stable expression of the Pak dominant negative mutants.
引用
收藏
页码:5139 / 5144
页数:6
相关论文
共 37 条
[1]   IDENTIFICATION OF A MOUSE P21(CDC42/RAC) ACTIVATED KINASE [J].
BAGRODIA, S ;
TAYLOR, SJ ;
CREASY, CL ;
CHERNOFF, J ;
CERIONE, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (39) :22731-22737
[2]  
BAGRODIA S, 1995, J BIOL CHEM, V270, P27995
[3]   THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS [J].
BALLESTER, R ;
MARCHUK, D ;
BOGUSKI, M ;
SAULINO, A ;
LETCHER, R ;
WIGLER, M ;
COLLINS, F .
CELL, 1990, 63 (04) :851-859
[4]   INDUCTION OF MEMBRANE RUFFLING AND FLUID-PHASE PINOCYTOSIS IN QUIESCENT FIBROBLASTS BY RAS PROTEINS [J].
BARSAGI, D ;
FERAMISCO, JR .
SCIENCE, 1986, 233 (4768) :1061-1068
[5]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[6]   COOPERATIVE INTERACTION OF S-POMBE PROTEINS REQUIRED FOR MATING AND MORPHOGENESIS [J].
CHANG, EC ;
BARR, M ;
WANG, Y ;
JUNG, V ;
XU, HP ;
WIGLER, MH .
CELL, 1994, 79 (01) :131-141
[7]   THE SMALL GTP-BINDING PROTEINS RAC1 AND CDC42 REGULATE THE ACTIVITY OF THE JNK/SAPK SIGNALING PATHWAY [J].
COSO, OA ;
CHIARIELLO, M ;
YU, JC ;
TERAMOTO, H ;
CRESPO, P ;
XU, NG ;
MIKI, T ;
GUTKIND, JS .
CELL, 1995, 81 (07) :1137-1146
[8]  
COX AD, 1994, METHOD ENZYMOL, V238, P277
[9]   ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS [J].
DECLUE, JE ;
PAPAGEORGE, AG ;
FLETCHER, JA ;
DIEHL, SR ;
RATNER, N ;
VASS, WC ;
LOWY, DR .
CELL, 1992, 69 (02) :265-273
[10]   Actions of Rho family small G proteins and p21-activated protein kinases on mitogen-activated protein kinase family members [J].
Frost, JA ;
Xu, SC ;
Hutchison, MR ;
Marcus, S ;
Cobb, MH .
MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (07) :3707-3713